Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
University of Missouri School of Medicine, Columbia, Missouri, USA.
Otolaryngol Head Neck Surg. 2023 Nov;169(5):1200-1207. doi: 10.1002/ohn.377. Epub 2023 May 26.
Positive surgical margins in oral cavity squamous cell carcinoma are associated with cost escalation, treatment intensification, and greater risk of recurrence and mortality. The positive margin rate has been decreasing for cT1-T2 oral cavity cancer over the past 2 decades. We aim to evaluate positive margin rates in cT3-T4 oral cavity cancer over time, and determine factors associated with positive margins.
Retrospective analysis of a national database.
National Cancer Database 2004 to 2018.
All adult patients diagnosed between 2004 and 2018 who underwent primary curative intent surgery for previously untreated cT3-T4 oral cavity cancer with known margin status were included. Logistic univariable and multivariable regression analyses were performed to identify factors associated with positive margins.
Among 16,326 patients with cT3 or cT4 oral cavity cancer, positive margins were documented in 2932 patients (18.1%). Later year of treatment was not significantly associated with positive margins (odds ratio [OR] 0.98, 95% confidence interval [CI] 0.96-1.00). The proportion of patients treated at academic centers increased over time (OR 1.02, 95% CI 1.01-1.03). On multivariable analysis, positive margins were significantly associated with hard palate primary, cT4 tumors, advancing N stage, lymphovascular invasion, poorly differentiated histology, and treatment at nonacademic or low-volume centers.
Despite increased treatment at academic centers for locally advanced oral cavity cancer, there has been no significant decrease in positive margin rates which remains high at 18.1%. Novel techniques for margin planning and assessment may be required to decrease positive margin rates in locally advanced oral cavity cancer.
口腔鳞状细胞癌中的阳性切缘与成本增加、治疗强化以及复发和死亡风险增加有关。在过去的 20 年中,cT1-T2 口腔癌的阳性切缘率一直在下降。我们旨在评估随着时间的推移 cT3-T4 口腔癌的阳性切缘率,并确定与阳性切缘相关的因素。
国家数据库的回顾性分析。
2004 年至 2018 年国家癌症数据库。
纳入 2004 年至 2018 年间接受首次未经治疗的 cT3-T4 口腔癌根治性手术且已知切缘状态的所有成年患者。进行逻辑单变量和多变量回归分析,以确定与阳性切缘相关的因素。
在 16326 例 cT3 或 cT4 口腔癌患者中,有 2932 例(18.1%)记录到阳性切缘。治疗的后期年份与阳性切缘无显著相关性(比值比 [OR] 0.98,95%置信区间 [CI] 0.96-1.00)。治疗时间在学术中心的患者比例随着时间的推移而增加(OR 1.02,95%CI 1.01-1.03)。多变量分析显示,阳性切缘与硬腭原发、cT4 肿瘤、进展的 N 分期、淋巴血管侵犯、低分化组织学以及在非学术或低容量中心治疗显著相关。
尽管学术中心对局部晚期口腔癌的治疗有所增加,但阳性切缘率仍未显著下降,仍高达 18.1%。可能需要新的切缘规划和评估技术来降低局部晚期口腔癌的阳性切缘率。